Stockreport

Relay Therapeutics (RLAY) Valuation After Breakthrough Therapy Win And Narrower Loss Attracts Fresh Investor Interest [Yahoo! Finance]

Relay Therapeutics, Inc.  (RLAY) 
PDF Relay Therapeutics (RLAY) is back in focus after reporting a narrower than expected quarterly loss, higher year on year revenue, and securing FDA Breakthrough Therapy d [Read more]